Mucocutaneous Adverse Reactions to COVID-19 Vaccines: Do Excipients Play a Role?
作者信息
Bianchi Leonardo, Biondi Filippo, Hansel Katharina, Murgia Nicola, D'Arpino Alessandro, Tramontana Marta, Stingeni Luca
机构信息
Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
出版信息
Acta Derm Venereol. 2022 May 24;102:adv00724. doi: 10.2340/actadv.v102.2048.
Abstract
摘要
相似文献
1
Mucocutaneous Adverse Reactions to COVID-19 Vaccines: Do Excipients Play a Role?新型冠状病毒肺炎疫苗的皮肤黏膜不良反应：辅料起作用吗？
Acta Derm Venereol. 2022 May 24;102:adv00724. doi: 10.2340/actadv.v102.2048.
2
Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?深入研究新冠疫苗接种引起的过敏反应：mRNA疫苗在肥大细胞疾病中是否安全？
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):193-195. doi: 10.18176/jiaci.0680. Epub 2021 Feb 12.
3
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients.抗 SARS-CoV-2 疫苗的超敏反应：对赋形剂的嗜碱性粒细胞反应。
Vaccine. 2023 Jul 19;41(32):4693-4699. doi: 10.1016/j.vaccine.2023.06.039. Epub 2023 Jun 15.
4
COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.COVID 疫苗接种可在有疫苗或其成分过敏史的患者中进行：来自南澳大利亚一家专科诊所的经验。
Intern Med J. 2022 Nov;52(11):1884-1890. doi: 10.1111/imj.15888. Epub 2022 Jul 30.
5
Vaccine allergy: evidence to consider for COVID-19 vaccines.疫苗过敏：考虑用于 COVID-19 疫苗的证据。
Curr Opin Allergy Clin Immunol. 2021 Aug 1;21(4):401-409. doi: 10.1097/ACI.0000000000000762.
6
Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.新型mRNA新冠疫苗在重度过敏患者中的安全性
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):180-181. doi: 10.18176/jiaci.0683. Epub 2021 Mar 2.
7
Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.基于脂质纳米颗粒的新冠疫苗的过敏反应和过敏症
Mol Ther. 2021 Mar 3;29(3):898-900. doi: 10.1016/j.ymthe.2021.01.030. Epub 2021 Feb 5.
8
Skin atrophy after skin tests with corticosteroids for the diagnosis of SARS-CoV-2 vaccine excipients hypersensitivity.使用皮质类固醇进行皮肤试验以诊断SARS-CoV-2疫苗辅料超敏反应后的皮肤萎缩。
Eur Ann Allergy Clin Immunol. 2023 Nov;55(6):319-322. doi: 10.23822/EurAnnACI.1764-1489.282. Epub 2023 Jan 13.
9
The role of lymphocyte transformation tests (LTT) in suspected severe delayed hypersensitivity reactions following COVID-19 vaccination.淋巴细胞转化试验（LTT）在疑似 COVID-19 疫苗接种后严重迟发性超敏反应中的作用。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2182527. doi: 10.1080/21645515.2023.2182527. Epub 2023 Mar 13.
10
Oral mucous membrane pemphigoid after SARS-CoV-2 vaccination.新型冠状病毒2型疫苗接种后发生的口腔黏膜类天疱疮
Oral Dis. 2024 Mar;30(2):782-783. doi: 10.1111/odi.14468. Epub 2022 Dec 28.
本文引用的文献
1
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.mRNA-1273加强疫苗接种后对SARS-CoV-2奥密克戎变体的中和作用。
N Engl J Med. 2022 Mar 17;386(11):1088-1091. doi: 10.1056/NEJMc2119912. Epub 2022 Jan 26.
2
Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work-up and decision points for vaccination during the COVID-19 pandemic.患者队列中对聚乙二醇和聚山梨酯的过敏反应：COVID-19大流行期间疫苗接种的诊断检查及决策要点
Clin Transl Allergy. 2022 Jan 8;12(1):e12111. doi: 10.1002/clt2.12111. eCollection 2022 Jan.
3
Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.接种 COVID-19 疫苗后的皮肤表现：世界文献复习和自身经验。
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):172-180. doi: 10.1111/jdv.17744. Epub 2021 Nov 2.
4
Tolerability of polysorbate 80-containing COVID-19 vaccines in confirmed polyethylene glycol-allergic patients.聚山梨酯80型新冠疫苗在确诊的聚乙二醇过敏患者中的耐受性
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4470-4472.e1. doi: 10.1016/j.jaip.2021.09.039. Epub 2021 Oct 6.
5
PEG/Polysorbate Skin Testing Has No Utility in the Assessment of Suspected Allergic Reactions to SARS-CoV-2 Vaccines.聚乙二醇/聚山梨酯皮肤试验在评估对SARS-CoV-2疫苗的疑似过敏反应中没有作用。
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3321-3322. doi: 10.1016/j.jaip.2021.06.025. Epub 2021 Jul 31.
6
Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.接种 SARS-CoV-2 疫苗后的皮肤反应：一项对 405 例病例的西班牙全国性横断面研究。
Br J Dermatol. 2022 Jan;186(1):142-152. doi: 10.1111/bjd.20639. Epub 2021 Sep 21.
7
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.mRNA COVID-19 疫苗首剂过敏反应：赋形剂皮肤试验作用有限。
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3308-3320.e3. doi: 10.1016/j.jaip.2021.06.010. Epub 2021 Jun 22.
8
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.新型冠状病毒疫苗过敏反应风险及推荐评估和管理：系统评价、荟萃分析、GRADE 评估和国际共识方法。
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3546-3567. doi: 10.1016/j.jaip.2021.06.006. Epub 2021 Jun 18.
9
Skin tests in urticaria/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: Limits of intradermal testing.荨麻疹/血管性水肿及辉瑞-生物科技公司新冠病毒疫苗引起的潮红反应中的皮肤试验：皮内试验的局限性
Allergy. 2021 Aug;76(8):2605-2607. doi: 10.1111/all.14839. Epub 2021 Apr 22.
10
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.欧洲过敏与临床免疫学会关于严重 COVID-19 疫苗过敏反应的诊断、管理和预防的声明
Allergy. 2021 Jun;76(6):1629-1639. doi: 10.1111/all.14739.
Zotero 插件